Home/Pipeline/Clinical Trial Integration

Clinical Trial Integration

Cardiovascular Disease

VariousActive

Key Facts

Indication

Cardiovascular Disease

Phase

Various

Status

Active

Company

Aktiia

About Aktiia

Aktiia is a pioneering medical device company that has developed the first CE-marked, cuffless blood pressure monitor for 24/7 automated measurement. Its core technology, based on optical sensors and proprietary algorithms, has been validated in multiple clinical trials published in peer-reviewed journals like Nature. The company is commercializing its Class IIa medical device across Europe, targeting both consumer health and clinical research markets with a data-driven approach to hypertension management.

View full company profile

Therapeutic Areas

Cardiovascular Disease Hypertension

Other Cardiovascular Disease Drugs

Drug	Company	Phase	Status
Manocept Diagnostic	Navidea Biopharmaceuticals	Research	Jeopardized (Bankruptcy)
Undisclosed Therapeutic Program(s)	HeartcoR Solutions	Pre-clinical	Active
Ramatroban (KAR101)	KARE Biosciences	Preclinical	Active
Undisclosed Cardiovascular Device Program	Transluminal Technologies	Pre-clinical	Active
iPSC-CM Cell Therapy	Khloris Biosciences	Research	Active
Cardiovascular Disease Study	Arizona Research Center	Not Specified	Active - Enrolling
Cardiovascular Clinical Trials	PanThera Bio	Not Specified	Active
Undisclosed	Zecardio Therapeutics	Discovery/Pre-clinical	Active
HDL/LDL Regulation	Alpha-1 Biologics	Pre-clinical	Active
Cardiovascular Program	Helixomer	Research	Active
Undisclosed Cardiovascular Program	inQB8 Medical Technologies	Pre-clinical	Active
Undisclosed Cardiovascular Program(s)	Salubris Biotherapeutics	Clinical-stage (phase unspecified)	Active